Search research articles
Contact Us
Filters
Showing results (181-190 of 440) with videos related to
Page
of 44
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2020
DGKA Provides Platinum Resistance in Ovarian Cancer Through Activation of c-JUN-WEE1 Signaling
Jie Li, Chaoyun Pan, Austin C Boese, et al.
Blood Cancer Journal
|
February 22, 2023
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience
Kathryn T Maples, Kevin H Hall, Nisha S Joseph, et al.
Research Square
|
April 1, 2024
The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination
Frances Lee, Doan Nguyen, Ian Hentenaar, et al.
Blood
|
April 10, 2014
MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells
Yanyan Gu, Jonathan L Kaufman, Leon Bernal, et al.
Transfusion
|
September 3, 2015
Plerixafor in combination with granulocyte-colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial
Neera Jagirdar, R Donald Harvey, Ajay Nooka, et al.
Haematologica
|
May 5, 2022
β adrenergic signaling regulates hematopoietic stem and progenitor cell commitment and therapy sensitivity in multiple myeloma
Remya Nair, Vimal Subramaniam, Benjamin G Barwick, et al.
Expert Opinion on Pharmacotherapy
|
November 14, 2018
Ixazomib for the treatment of multiple myeloma
Paul G Richardson, Sonja Zweegman, Elizabeth K O'Donnell, et al.
Blood
|
December 2, 2006
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study
Asher A Chanan-Khan, Jonathan L Kaufman, Jayesh Mehta, et al.
Scientific Reports
|
February 13, 2024
Majority of human circulating IgG plasmablasts stop blasting in a cell-free pro-survival culture
Doan C Nguyen, Celia Saney, Ian T Hentenaar, et al.
Blood
|
September 17, 2010
Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes
Ebenezer David, Jonathan L Kaufman, Christopher R Flowers, et al.
Page
of 44
Search research articles
Search
Showing results (181-190 of 440) with videos related to
Sort By:
Page
of 44
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2020
DGKA Provides Platinum Resistance in Ovarian Cancer Through Activation of c-JUN-WEE1 Signaling
Jie Li, Chaoyun Pan, Austin C Boese, et al.
Blood Cancer Journal
|
February 22, 2023
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience
Kathryn T Maples, Kevin H Hall, Nisha S Joseph, et al.
Research Square
|
April 1, 2024
The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination
Frances Lee, Doan Nguyen, Ian Hentenaar, et al.
Blood
|
April 10, 2014
MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells
Yanyan Gu, Jonathan L Kaufman, Leon Bernal, et al.
Transfusion
|
September 3, 2015
Plerixafor in combination with granulocyte-colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial
Neera Jagirdar, R Donald Harvey, Ajay Nooka, et al.
Haematologica
|
May 5, 2022
β adrenergic signaling regulates hematopoietic stem and progenitor cell commitment and therapy sensitivity in multiple myeloma
Remya Nair, Vimal Subramaniam, Benjamin G Barwick, et al.
Expert Opinion on Pharmacotherapy
|
November 14, 2018
Ixazomib for the treatment of multiple myeloma
Paul G Richardson, Sonja Zweegman, Elizabeth K O'Donnell, et al.
Blood
|
December 2, 2006
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study
Asher A Chanan-Khan, Jonathan L Kaufman, Jayesh Mehta, et al.
Scientific Reports
|
February 13, 2024
Majority of human circulating IgG plasmablasts stop blasting in a cell-free pro-survival culture
Doan C Nguyen, Celia Saney, Ian T Hentenaar, et al.
Blood
|
September 17, 2010
Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes
Ebenezer David, Jonathan L Kaufman, Christopher R Flowers, et al.
Page
of 44